This is from Reddit : Spot on 13D supporters. (
Post# of 148170
13D supporters. (Thoughtful Investing) Send me a link to Incell DX's drug trials. All none of them please. Bruce Patterson's Phase 3 drug trials would be great too. Guessing they have the same link.
Opinion
Here's Cytodyn's. https://clinicaltrials.gov/ct2/results?cond=&...&dist=
22 in total, including a very successful Phase 2 Long Hauler Trial. You realize that there were people in wheel chairs at the beginning of that study, and walked out of it at the end and its not because they were leaning on the arm of Bruce Patterson. You're actually complaining that you can't see a Phase 3 Trial yet when they have 22 different Trials in one stage or another. You proclaim BP as a hero with his none trials and Nader as incompetent with his 22 trials , not to mention some crazy exciting results in Breast Cancer that I won't even get into. You admit the drug works. You admit it should be approved. And yet all your arrows fly around the FDA into Nader, while you lift Bruce Patterson up as the man that would see it done.
Personally, I think Dr. Patterson is a very intelligent and gifted human being. To listen to the man, I find him personally likeable, but he's no replacement for Nader as CEO, and none of you even pretend he is. Whatever he replaces, I have questions. I have concerns about his integrity. That Patent issue and the 13D so called justification is a major problem for me. The lack of transparency is a problem for me. And I really don't like what I've seen out of some of the people that have rallied both to him and Incell DX that used to be very supportive of Leronlimab and Cytodyn and have turned on a dime, much like Thoughtful, and have been so ferocious in their criticisms. The coordination of the message points, and the timing, and the vehement change, it makes me very, very suspicious. Especially when some of these guys are suddenly working with Incell Dx. It's odd.
I imagine Thoughtful will credit his change to the Phase 3 CDO 12 and the missed primary endpoint because the age range wasn't accounted for. Cytodyn's response is they didn't know as much about the disease at the time they created the trial, and they honestly didn't account for it. A definite bummer if so, but that's what they call experience, and that's what these trials are supposed to help acquire.
But I have to point this out. Do you REALLY think Nader designed the study? The 13D's continue to lay that at his feet, like he put it together between meetings and at home while he watched TV. You know as well as I that he hired people to put together and oversee the trial, and the man of honor that he is, he refused to throw anyone under the bus, when there was only personal upside for him do so. All of use would have gone along with it. There were even some that wondered if someone intentionally tanked the study on behalf of Big Pharma. But Nader didn't say anything negative about anyone, to include the FDA for that matter. He actually defended all of them, and I respect that and I give him the benefit of the doubt as a missed opportunity that won't be missed again.
But the 13D solution is to give the company that he single handedly saved, to a group that has NEVER accomplished anything in the range of what we need accomplished. A significant portion of this group by the way has a lot of history with Cytodyn and very little of it is good. Personally, I think it would be a horrible mistake. I find the way this has been presented distasteful. I don't trust the group that has been assembled or the plan that we have yet to see. But it really doesn't matter. Even if I didn't have those issues, I honestly believe there is one man in the world that knows exactly how to run Cytodyn with no loss of momentum, and he's running it. Statistically he's poised. He's got a lot of hooks in the water and I believe in him, and the drug, and the hooks. One is going to hit, and when it does, even if the FDA is as corrupt as so many fear, my prayer is it will be so conclusive that it will overwhelm that as well if it exists.
We are far more poised for success than we were when Thoughtful Investing was telling all of us that $7 a share was a bargain... Nash, Brazil, HIV BLA, Cancer... any one of these hit and Nader will make all of you far more revenue than your loyalty deserves, but that's okay. I'd love to see it happen. But when it does will you put as much energy into apologizing to the man as you've spent vilifying him?